SBSophia Björkander

Sophia Björkander

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sophia Björkander has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecular profiling of repeated self-sampled blood reveals dynamic immune phenotypes in young adults

    by Annika Bendes, Sophia Björkander, Maura M. Kere, Simon Kebede Merid, Ashish Kumar, Leo Dahl, Tess D. Pottinger, Zhebin Yu, Anna Gardell, Amelie Vogt, et al.

    Although population-based studies of circulating blood proteins have provided profound insight into human biology, transient changes to time-dependent exposures often remain elusive. Here, we perform a longitudinal dried blood spot (DBS) self-sampling study in 808 young adults (aged 24–27, 64% females) from the Swedish Barn [Children], Allergy, Milieu, Stockholm Epidemiology cohort. In total, we collected ~2400 samples from 2020 to 2022. Each sample was profiled for SARS-CoV-2 serological, anti-interferon autoantibodies (AAbs), and 365 inflammation-related proteins. We subsequently linked these samples to registry-confirmed infection and vaccination exposures, physiological traits, genetic variation, and blood counts. We show that data-driven seroclustering captures the response to both infection and vaccination exposures, while stable AAbs against interferon receptors IFNAR1 and IFNGR2 associate with the duration of self-reported COVID-19 symptoms. Genome-wide mapping reveals 664 protein quantitative trait loci (pQTL) across 65 proteins, with cis -pQTLs associated proteins showing greater longitudinal stability. Paired pre- and post-exposure samples indicate temporal changes in protein levels after infection (LAP3) and vaccination (TIMP3). This multi-molecular epidemiological profiling of self-sampled blood captures dynamic immune trajectories and shorter-term variability in a population of young adults.

  • Open Access

    Longitudinal protein profiling of blood during childhood into early adulthood

    by Sofia Bergström, Sophia Björkander, María Bueno Álvez, Simon Kebede Merid, Hanna Danielsson, Anna Bergström, Inger Kull, Anne-Sophie Merritt, Fredrik Edfors, Susanna Klevebro, et al.

    Proteomic research enhances our understanding of health- and disease-related biological processes. Protein profiling during healthy childhood provides important insights into normal physiological development. We longitudinally measured 5416 plasma proteins at four follow-ups during childhood (4-, 8-, 16 years) and early adulthood (24 years) in 100 randomly selected subjects participating in a population-based Swedish cohort, using Olink Explore HT. In total, 3509 proteins were included in the analysis. 54% of the proteins were found to be associated with age, and we observed several protein trajectories from childhood to adulthood based on clustering. In addition to proteins involved in bone, teeth and cartilage formation, we identified differences in proteins involved in neural function, drug metabolism, and hormonal control. There were pronounced sex-related differences in protein levels, particularly at follow-ups 16 and 24, characterized by, for example, growth, response to stimuli and regulation of catabolic processes. We demonstrate dynamic age- and sex-related changes in protein levels during the first two decades of life. Our study results may serve as an important resource in understanding human physiological development, disease etiology, and for future protein biomarker research.


  • Open Access

    Molecular profiling of repeated self-sampled blood reveals dynamic immune phenotypes in young adults

    by Annika Bendes, Sophia Björkander, Maura M. Kere, Simon Kebede Merid, Ashish Kumar, Leo Dahl, Zhebin Yu, Amelie Vogt, Changil Kim, Qiang Pan-Hammarström, et al.

    Population-based studies of circulating blood proteins have provided profound insights into human biology. However, short-lived changes often remained undetected. To address this, we performed a comprehensive longitudinal dried blood spot (DBS) self-sampling study in 808 young adults of the BAMSE cohort during 2020-2022. We profiled serological, autoimmune, and proteomic phenotypes in relation to SARS-CoV-2 exposures (infection, vaccination), physiological traits, genetic variation, and blood counts. Data-driven seroclustering revealed dynamic immune response to both exposures, while analysis of anti-interferon autoantibodies (AAbs) uncovered associations of pre-existing stable AAbs with prolonged COVID-19 symptoms. Genome-wide mapping determined 664 pQTLs, with cis-pQTLs associated showing increased longitudinal stability. We also identified relationships between blood cell counts and DBS proteins beyond the hematocrit effects. Paired pre- and post-exposure highlighted transient alterations for infection (e.g. LAP3) and vaccinations (e.g. TIMP3). Multi-molecular phenotyping in self-sampling can capture dynamic immune trajectories, informing precision medicine efforts with clinically valuable insights on short-term variability in health phenotypes.


  • Open Access

    Genetically Determined Inflammation‐Related Proteins in Asthma and Type‐2 Signatures

    by Natalia Hernandez‐Pacheco, Sophia Björkander, Simon Kebede Merid, Maura Kere, Ashish Kumar, Susanna Klevebro, Ida Mogensen, Sandra Ekström, Christer Janson, Lena Palmberg, et al.

    Background: Protein quantitative trait loci (pQTLs) remain underexplored in asthma but might provide valuable insights into the underlying molecular mechanisms. This study aimed to investigate associations between genetic variation and inflammation‐related plasma proteins and to assess differences in the levels of genetically determined proteins in subjects with signatures of type‐2 inflammation and/or asthma.Methods: A pQTL mapping of 92 inflammation‐related plasma proteins was conducted in young adults from the Swedish BAMSE cohort (n = 1538). Replication of sentinel pQTLs was attempted, and the overlap and colocalization of pQTLs with expression quantitative trait loci (eQTLs) were investigated using publicly available data. Proteins with significant pQTLs were tested for association with type‐2 signatures defined as high levels of fractional exhaled nitric oxide, blood eosinophils, and/or sensitization to airborne allergens in subjects with or without asthma in BAMSE.Results: Forty‐five sentinel pQTLs (33 cis, 12 trans) for 39 inflammation‐related proteins were identified (p ≤ 7.14 × 10−11), and a high proportion of these were validated in independent populations. A high likelihood for colocalization of cis‐pQTLs and cis‐eQTLs was observed for 19 proteins in different tissues. Six of the 39 circulating proteins with significant pQTLs were associated with type‐2 signatures and/or asthma, and matrix metalloproteinase‐10 (MMP‐10) showed the most significant associations.Conclusions: These findings underscore the existence of a genetic component influencing the plasma levels of proteins involved in inflammatory processes, including MMP‐10, which is suggested to have a role in high type‐2 inflammation in asthma subjects.


  • Open Access

    Multi-molecular phenotyping in a self-sampling population

    by Leo Dahl, Annika Bendes, María Bueno Álvez, Vincent Albrecht, Hooman Aghelpasand, Sophia Björkander, Simon Kebede Merid, Anja Mezger, Max Käller, Claudia Fredolini, et al.

    The recent COVID-19 pandemic has posed major health challenges. To expand our molecular understanding beyond those seeking medical care, we conducted a cross-sectional survey targeting random residents from Sweden’s two largest cities. Two thousand participants were invited during 2021 to self-sample dried blood spots (DBS) and provide health information. DBS samples were analysed for multiple anti-SARS-CoV-2 antibodies (Abs), auto-reactive antibodies (AAbs) against 23 interferons (IFNs), and for 502 circulating immune-related proteins. Data-driven methodologies characterised the DBS phenotypes in response to infections and vaccination. We received DBS samples from 437 (22%) volunteers aged 18-69, 60% females, and 50% per city. Multi-analyte serology distinguished self-reported infections (26%) and vaccination (40%), revealing a time-dependent discrepancy between reported and measured immunity. Anti-IFN Abs were detected in 21% of the donors and more frequent for type 1 IFNs alongside a natural infection. Integrating proteomics with antibody data provided additional insights into processes of cell-mediated immunity. Proteomics-centric analysis identified 24% of the participants to deviate in their phenotypes due to infection, immunity, respiratory distress, and age-related traits. Multi-molecular analysis of layperson samples uncovered heterogeneity and diversity of immunity and health phenotypes, complementing clinical investigations.

  • Open Access

    The allergic phenotype during the first 10 years of life in a prospective cohort

    by Sophia Björkander, Jenny Hallberg, Jan‐Olov Persson, Gunnar Lilja, Caroline Nilsson, Eva Sverremark‐Ekström

    Background: Heredity and environmental parameters jointly affect allergy development. Here, we used a Swedish prospective cohort to study the influence of heredity and factors usually associated with allergic disease and the development of allergic manifestations in combination with immunoglobulin E (IgE) sensitization at four different time points until 10 years of age.Methods: Parents‐to‐be were characterized concerning allergy and their children (n = 281) were divided based on allergic heredity and followed from birth and clinically examined for IgE‐associated allergic symptoms until 10 years of age. The relation between allergy and early‐life parameters was analyzed by logistic regression. Group‐wise comparisons were made by nonparametrical tests.Results: Early life eczema and/or asthma in combination with IgE sensitization, was a strong indicator of allergy at a later time point. Further, the early occurrence of multiple allergic symptoms among IgE‐sensitized children predisposed for a more complex allergic phenotype at later ages, independently of allergic heredity. At 10 years of age, allergic children had higher fractional exhaled nitrogen oxide (FeNO) levels, regardless of asthma, and FeNO levels were also influenced by heredity. Birth season was strongly associated with allergy development, but only in children with two allergic parents.Conclusion: Allergic eczema/asthma in early life, being born during the autumn/winter, having multiple allergic symptoms and two allergic parents were all strong predictors for having allergic diseases at 5 and 10 years of age. However, the allergic march seems to be independent of heredity, as IgE‐mediated allergies follow the same trajectories in children with and without allergic heredity.